{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 445221983
| IUPAC_name = 7-(1,2-dimethylheptyl)-2,2-dimethyl-4-(4-pyridinyl)-2H-1-benzopyran-5-ol
| image = Nonabine.png
| width = 240

<!--Clinical data-->
| tradename =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 16985-03-8
| ATC_prefix = none
|  PubChem = 71885
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 64899
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 77DUK856J7

<!--Chemical data-->
| C=25 | H=33 | N=1 | O=2 
| molecular_weight = 379.534 g/mol
| smiles = CCCCCC(C)C(C)c1cc(c2c(c1)OC(C=C2c3ccncc3)(C)C)O
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C25H33NO2/c1-6-7-8-9-17(2)18(3)20-14-22(27)24-21(19-10-12-26-13-11-19)16-25(4,5)28-23(24)15-20/h10-18,27H,6-9H2,1-5H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = YHUDSHIRWOVVCV-UHFFFAOYSA-N
}}

'''Nonabine''' ('''BRL-4664''') is a drug which is a [[cannabinoid]] derivative, which was developed for the prevention of [[nausea]] and [[vomiting]] associated with [[cancer]] [[chemotherapy]].<ref>Staquet M, Bron D, Rozencweig M, Kenis Y. Clinical studies with a THC analog (BRL-4664) in the prevention of cisplatin-induced vomiting. ''Journal of Clinical Pharmacology''. 1981 Aug-Sep;21(8-9 Suppl):60S-63S. {{PMID|7197692}}</ref> It has strong [[antiemetic]] effects equivalent to those of [[chlorpromazine]], and also produces some mild [[sedative]] effects, along with [[dry mouth]] and [[EEG]] changes typical of cannabinoid agonists, but with minimal changes in mood or perception, suggesting the abuse potential is likely to be low.<ref>Archer CB, Amlot PL, Trounce JR. Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine. ''British Medical Journal (Clinical Research Edition)''. 1983 Jan 29;286(6362):350-1. {{PMID|6402096}}</ref><ref>McClelland GR, Sutton JA. Pilot investigation of the quantitative EEG and clinical effects of ketazolam and the novel antiemetic nonabine in normal subjects. ''Psychopharmacology''. 1985;85(3):306-8. {{PMID|2860687}}</ref>

== References ==
<references/>

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Antiemetics]]
[[Category:Cannabinoids]]
[[Category:Pyridines]]
[[Category:Phenols]]
[[Category:Chromenes]]


{{gastrointestinal-drug-stub}}
{{cannabinoid-stub}}